Acute Respiratory Distress Syndrome and the Use of Inhaled Pulmonary Vasodilators in the COVID-19 Era: A Narrative Review

The Coronavirus disease (COVID-19) pandemic of 2019 has resulted in significant morbidity and mortality, especially from severe acute respiratory distress syndrome (ARDS). As of September 2022, more than 6.5 million patients have died globally, and up to 5% required intensive care unit treatment. CO...

Descripción completa

Detalles Bibliográficos
Autores principales: Nasrullah, Adeel, Virk, Shiza, Shah, Aaisha, Jacobs, Max, Hamza, Amina, Sheikh, Abu Baker, Javed, Anam, Butt, Muhammad Ali, Sangli, Swathi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9695622/
https://www.ncbi.nlm.nih.gov/pubmed/36362921
http://dx.doi.org/10.3390/life12111766

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9695622/
https://www.ncbi.nlm.nih.gov/pubmed/36362921
http://dx.doi.org/10.3390/life12111766

Ejemplares similares